XML 14 R4.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Income Statement [Abstract]    
Research and development expenses $ 642 $ 460
General and administrative expenses 642 633
Total operating expenses 1,284 1,093
Operating loss 1,284 1,093
Financing expense, net 2
Loss for the period 1,286 1,093
Other comprehensive income:    
Foreign currency translation income (5) (7)
Comprehensive loss for the period $ 1,281 $ 1,086
Loss per share (Basic and Diluted) $ (0.08) $ (0.07)
Weighted average number of common stock outstanding used in computing basic and diluted net loss per share 15,503,632 15,461,757